News & Insights
Publications
Flow diverter deployment planning using PreSize® Neurovascular medical software
Presentation at the 12th ESMINT Congress
- 10/09/2020
Flow diverter deployed length prediction by computational simulation in PreSize® Neurovascular medical software: a retrospective study
Presentation at the ABC-WIN Seminar
- 17/01/2020
Virtual flow diverter treatment planning: The effect of device placement on bifurcation aneurysm haemodynamics
Special issue article in the Journal of Engineering in Medicine
- 25/10/2016
Towards predicting patient-specific flow diverter treatment outcomes for bifurcation aneurysms: from implantation rehearsal to virtual angiograms
Published in the Annals of Biomedical Engineering
- 04/08/2015
Comparison and calibration of a real-time virtual stenting algorithm using Finite Element Analysis and Genetic Algorithms
Published in Computer Methods in Applied Mechanics and Engineering
- 22/04/2015
Personalising flow diverter intervention for cerebral aneurysms: from computational hemodynamics to biochemical modelling
Published in the International Journal for Numerical Methods in Biomedical Engineering
- 07/07/2014
Which Spring is the Best? Comparison of Methods for Virtual Stenting
Published in IEEE Transactions on Biomedical Engineering
- 14/06/2014
Oxford Heartbeat's software PreSize® Neurovascular is on track to be introduced within the NHS.
Interview with Enterprising Oxford
19/10/2020
Our CEO Katerina shares her insights on how entrepreneurship has enabled her to contribute to medicine.
Oxford Heartbeat wins AI in Health and Care Award
08/09/2020
Oxford Heartbeat's software PreSize® Neurovascular is on track to be introduced within the NHS.
Interview with the Royal Academy of Engineering
01/07/2020
Our CEO Katerina, a Royal Academy of Engineering Fellow, speaks about the joys and challenges of entrepreneurship.
Feature on CE marking with DigitalHealth.London
27/05/2020
Acquiring CE marking for novel medical devices is often a complex process.
Oxford Heartbeat is awarded CE marking
16/03/2020
PreSize® Neurovascular is now deemed ready for market release at all hospitals across the EU and UK.